These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28721827)

  • 1. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and Oxidative Stress in the Diabetic State: Clinical Implications and Potential Therapeutic Applications.
    Espino J; Rodríguez AB; Pariente JA
    Curr Med Chem; 2019; 26(22):4178-4190. PubMed ID: 29637854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.
    Shlomai G; Neel B; LeRoith D; Gallagher EJ
    J Clin Oncol; 2016 Dec; 34(35):4261-4269. PubMed ID: 27903154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant properties of melatonin and its potential action in diseases.
    Karaaslan C; Suzen S
    Curr Top Med Chem; 2015; 15(9):894-903. PubMed ID: 25697560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.
    Winczyk K; Pawlikowski M; Lawnicka H; Kunert-Radek J; Spadoni G; Tarzia G; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():50-4. PubMed ID: 12019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin and pancreatic cancer: Current knowledge and future perspectives.
    Tamtaji OR; Mirhosseini N; Reiter RJ; Behnamfar M; Asemi Z
    J Cell Physiol; 2019 May; 234(5):5372-5378. PubMed ID: 30229898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Oxid Med Cell Longev; 2018; 2018():9698258. PubMed ID: 29743988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials.
    Seely D; Wu P; Fritz H; Kennedy DA; Tsui T; Seely AJ; Mills E
    Integr Cancer Ther; 2012 Dec; 11(4):293-303. PubMed ID: 22019490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function.
    Yaribeygi H; Atkin SL; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8402-8410. PubMed ID: 30417488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer.
    Winczyk K; Pawlikowski M; Guerrero JM; Karasek M
    Tumour Biol; 2002; 23(5):298-302. PubMed ID: 12595746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin with adenosine solubilized in water and stabilized with glycine for oncological treatment - technical preparation, effectivity and clinical findings.
    Di Bella G; Gualano L; Di Bella L
    Neuro Endocrinol Lett; 2017 Dec; 38(7):465-474. PubMed ID: 29369596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin and Docosahexaenoic Acid Decrease Proliferation of PNT1A Prostate Benign Cells via Modulation of Mitochondrial Bioenergetics and ROS Production.
    Tamarindo GH; Ribeiro DL; Gobbo MG; Guerra LHA; Rahal P; Taboga SR; Gadelha FR; Góes RM
    Oxid Med Cell Longev; 2019; 2019():5080798. PubMed ID: 30728886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.
    Lissoni P; Giani L; Zerbini S; Trabattoni P; Rovelli F
    Nat Immun; 1998; 16(1):27-33. PubMed ID: 9789122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin protects the heart and pancreas by improving glucose homeostasis, oxidative stress, inflammation and apoptosis in T2DM-induced rats.
    Abdulwahab DA; El-Missiry MA; Shabana S; Othman AI; Amer ME
    Heliyon; 2021 Mar; 7(3):e06474. PubMed ID: 33748504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin's protective actions.
    Rafiyan M; Davoodvandi A; Reiter RJ; Mansournia MA; Rasooli Manesh SM; Arabshahi V; Asemi Z
    Pathol Res Pract; 2024 Jan; 253():155031. PubMed ID: 38103362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer.
    Maestroni GJ
    Adv Exp Med Biol; 1999; 467():217-26. PubMed ID: 10721059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.